Tag:
Abbott Labs
Latest Headlines
Latest Headlines
Insider trading investigation eyes Abbott/Advanced Medical Optics deal
An ongoing insider trading investigation focused on Abbott Labs' $3 billion acquisition of Advanced Medical Optics in 2009 is getting extremely juicy.
Pfizer, J&J, Abbott facing shortages of crucial ingredients in Pakistan
The American Business Council has warned authorities that they had better get the matter sorted out or the country will soon face shortages.
Abbott touts positive Parkinson's Phase III as pharma split looms
Banking on double-digit earnings growth and a string of pipeline deals and developments, Abbott Laboratories execs said they are "on track" to go ahead and spin off the pharma side of the business later this year.
Abbott gains Japanese nod for Xience Prime
Japanese regulators have signed off on Abbott's ( $ABT ) next-generation Xience Prime drug-eluting coronary stent, granting approval for its use to treat clogged arteries.
Abbott gets more incentives for its new Ensure plant
More incentives are trickling into Abbott to help offset the cost of its $270 million manufacturing plant being built in Tipp City near Dayton, OH.
Abbott's White saw compensation drop in 2011
Abbott Laboratories ( $ABT ) had a memorable 2011 capped off by announcing that it would split into two companies: a pharma business and a medical products company. CEO Miles White (pictured), who will continue to lead the diversified medical products company, saw his total compensation fall slightly in 2011, coming in at just above $24 million. That's down about 6% from $25.6 million a year earlier.
Abbott, Merck keep companion Dx trend going with cancer test
We've been hearing a lot about companion diagnostics lately--especially as to how they can help save the healthcare system money by identifying those patients who might respond to certain treatments.
Abbott's deal-team delivers $1.35B Galapagos RA pact
Abbott ( $ABT ) today revealed that it is paying Belgian biotech Galapagos $150 million upfront to license in a promising oral treatment for rheumatoid arthritis .
13 Big Pharmas to collaborate on $785M fight against neglected diseases
Top executives from a slate of the world's biggest pharma companies will be rubbing shoulders with Bill Gates today as they roll out an ambitious plan to join hands on a $785 million effort to
Abbott to cut 700 jobs as Promus sales decline
Despite reporting healthy profits this week, Abbott Labs ( $ABT ) is laying off 700 people in the U.S. and Puerto Rico as part of a restructuring effort. Roughly 200 positions will be eliminated at its
